Skip to main content

Table 3 Distribution of histological groups and selected histologies, year of diagnosis 2013

From: Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany

Diagnostic group

Men

Women

Sex ratio (M/F)

Cases

Incidence rate per 100,000 per year

Age at diagnosis (Median)

Cases

Incidence rate per 100,000 per year

Age at diagnosis (Median)

 

N

%

Crude

Age-standa

N

%

Crude

Age-standa

 

Sarcoma, NOS

645

18.9

1.9

1.3

71.4

470

13.7

1.3

0.8

71.5

1.4: 1

 Sarcoma, NOS

317

9.3

0.9

0.6

71.9

290

8.4

0.8

0.5

71.5

1.1: 1

 Spindle cell sarcoma

72

2.1

0.2

0.1

73.5

53

1.5

0.1

0.1

73.4

1.4: 1

 Giant cell sarcoma

170

5.0

0.5

0.3

72.9

87

2.5

0.2

0.1

72.5

2: 1

 Small cell sarcoma

7

0.2

0.0

0.0

41.8

3

0.1

0.0

0.0

46.2

2.3: 1

 Undifferentiated sarcoma

42

1.2

0.1

0.1

64.4

21

0.6

0.1

0.0

64.0

2: 1

Fibrosarcoma

475

14.0

1.4

1.0

71.0

305

8.9

0.9

0.6

61.5

1.6: 1

 Fibrosarcoma, NOS

48

1.4

0.1

0.1

64.0

36

1.0

0.1

0.1

67.3

1.3: 1

 Fibromyxosarcoma

82

2.4

0.2

0.2

70.3

59

1.7

0.2

0.1

68.3

1.4: 1

 Malignant fibrous histiocytoma

198

5.8

0.6

0.3

77.0

77

2.2

0.2

0.1

74.3

2.6: 1

 Dermatofibrosarcoma, NOS

93

2.7

0.3

0.2

50.2

95

2.8

0.3

0.2

45.8

1: 1

Liposarcoma

393

11.5

1.1

0.8

65.9

250

7.3

0.7

0.5

65.3

1.6: 1

 Liposarcoma, NOS

144

4.2

0.4

0.3

70.2

111

3.2

0.3

0.2

68.5

1.3: 1

 Liposarcoma, well differentiated

56

1.6

0.2

0.1

63.5

37

1.1

0.1

0.1

62.2

1.5: 1

 Myxoid liposarcoma

69

2.0

0.2

0.2

56.5

41

1.2

0.1

0.1

52.8

1.7: 1

 Dedifferentiated liposarcoma

89

2.6

0.3

0.2

70.8

32

0.9

0.1

0.1

69.6

2.8: 1

Uterine leiomyosarcoma

0

0.0

0.0

0.0

.

109

3.2

0.3

0.2

60.4

Non-uterine leiomyosarcoma

277

8.1

0.8

0.6

70.5

330

9.6

0.9

0.6

67.3

1: 1.2

Rhabdomyosarcoma

78

2.3

0.2

0.3

25.2

47

1.4

0.1

0.1

48.7

1.7: 1

 Rhabdomyosarcoma, NOS

19

0.6

0.1

0.1

53.3

18

0.5

0.1

0.0

56.3

1.1: 1

 Embryonal rhabdomyosarcoma

20

0.6

0.1

0.1

14.2

9

0.3

0.0

0.0

12.4

2.2: 1

Complex Neoplasia

169

5.0

0.5

0.4

61.2

741

21.5

2.1

1.3

69.8

1: 4.4

 Endometrial stromal sarcoma, NOS

0

0.0

0.0

0.0

.

75

2.2

0.2

0.1

62.2

 Endometrial stromal sarcoma, low grade

0

0.0

0.0

0.0

.

36

1.0

0.1

0.1

53.3

 Adenosarcoma

0

0.0

0.0

0.0

.

28

0.8

0.1

0.1

61.1

 Mullerian mixed tumor

0

0.0

0.0

0.0

.

206

6.0

0.6

0.3

72.6

 Carcinosarcoma, NOS

37

1.1

0.1

0.1

71.5

260

7.6

0.7

0.4

73.0

1: 7

 Synovial sarcoma, NOS

32

0.9

0.1

0.1

56.2

28

0.8

0.1

0.1

49.5

1.1: 1

 Synovial sarcoma, spindle cell

20

0.6

0.1

0.1

40.4

13

0.4

0.0

0.0

52.0

1.5: 1

Phylloides tumour, malignant

0

0.0

0.0

0.0

.

56

1.6

0.2

0.1

56.2

Angiosarcoma

233

6.8

0.7

0.5

69.5

168

4.9

0.5

0.3

72.8

1.4: 1

 Haemangiosarcoma, NOS

118

3.5

0.3

0.2

72.5

122

3.5

0.3

0.2

74.7

1: 1

 Kaposi sarcoma

87

2.6

0.3

0.2

61.4

17

0.5

0.0

0.0

72.9

5.1: 1

Osteosarcoma

85

2.5

0.2

0.3

35.8

67

1.9

0.2

0.2

39.8

1.3: 1

 Osteosarcoma, NOS

69

2.0

0.2

0.2

42.0

49

1.4

0.1

0.1

45.3

1.4: 1

Chondrosarcoma

105

3.1

0.3

0.2

60.8

119

3.5

0.3

0.2

61.4

1: 1.1

 Chondrosarcoma, NOS

81

2.4

0.2

0.2

60.8

100

2.9

0.3

0.2

62.0

1: 1.2

Giant cell neoplasia

4

0.1

0.0

0.0

56.6

5

0.1

0.0

0.0

58.3

1: 1.3

Ewing family of tumours

107

3.1

0.3

0.4

24.7

70

2.0

0.2

0.2

25.1

1.5: 1

 Ewing sarcoma

93

2.7

0.3

0.3

23.7

56

1.6

0.2

0.2

23.7

1.7: 1

Malignant ameloblastoma

2

0.1

0.0

0.0

72.8

4

0.1

0.0

0.0

50.0

1: 2

Chordoma

34

1.0

0.1

0.1

63.6

30

0.9

0.1

0.1

58.0

1.1: 1

 Chordoma, NOS

30

0.9

0.1

0.1

64.5

27

0.8

0.1

0.1

58.0

1.1: 1

Nerve sheath tumours

63

1.9

0.2

0.2

57.7

52

1.5

0.1

0.1

55.6

1.2: 1

 Malignant peripheral nerve sheath tumour

56

1.6

0.2

0.1

57.6

43

1.2

0.1

0.1

56.0

1.3: 1

GIST

734

21.6

2.1

1.5

69.5

619

18.0

1.7

1.1

70.2

1.2: 1

  1. aage-standardized incidence rates per 100,000 (European standard 1976)
  2. Bold text: Main groups